Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis
Alzheimer's disease (AD) is a neurodegenerative disease that causes memory loss, cognitive decline, and eventually dementia. The etiology of AD and its pathological mechanisms remain unclear due to its complex pathobiology. At the same time, the number of patients with AD is increasing worldwid...
Saved in:
Main Author: | Toshihiko Tashima (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria
by: Arsalan S. Haqqani, et al.
Published: (2024) -
Affibody Molecules Intended for Receptor-Mediated Transcytosis via the Transferrin Receptor
by: Linnea Charlotta Hjelm, et al.
Published: (2023) -
Treatment of Neuronopathic Mucopolysaccharidoses with Blood-Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
by: Hiroyuki Sonoda, et al.
Published: (2022) -
Non-Invasive Device-Mediated Drug Delivery to the Brain across the Blood-Brain Barrier
by: Toshihiko Tashima, et al.
Published: (2024) -
Storax Inhibits Caveolae-Mediated Transcytosis at Blood-Brain Barrier After Ischemic Stroke in Rats
by: Min Zhou, et al.
Published: (2022)